Proteomic identification of proteins oxidized by Aβ(1-42) in synaptosomes: Implications for Alzheimer's disease

Brain Research

Volumn 1044, Issue 2, 2005, Pages 206-215

  Boyd Kimball, Debra ^a   Castegna, Alessandra ^a   Sultana, Rukhsana ^a   Poon, H Fai ^a   Petroze, Robin ^a   Lynn, Bert C ^a   Klein, Jon B ^c   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide (1 42); Amyloid peptide (42 1); Oxidative stress; Proteomics

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE; AMYLOID BETA PROTEIN[1-42]; BETA ACTIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN; ELONGATION FACTOR TU; GAMMA ACTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DEHYDROGENASE; SYNTAXIN 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CARBONYLATION; CONTROLLED STUDY; MALE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN TRANSPORT; STRUCTURAL PROTEOMICS;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BRAIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GERBILLINAE; MALE; MASS SPECTROMETRY; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PROTEINS; PROTEOMICS; SEQUENCE ANALYSIS, PROTEIN; SYNAPTOSOMES;

EID: 18844440651     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.02.086     Document Type: Article

References (69)

1. M.Y. Aksenov, H.M. Tucker, P. Nair, M.V. Askenova, D.A. Butterfield, S. Estus, and W.R. Markesbery The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase in different brain regions in Alzheimer's disease brain Neurochem. Res. 24 1999 767 774
2. M.Y. Aksenov, M.V. Aksenova, D.A. Butterfield, J.W. Geddes, and W.R. Markesbery Protein oxidation in the brain in Alzheimer's disease Neuroscience 103 2001 373 383
3. M.S. Albert, B.T. Hyman, and M.C. Irizzary Early accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain Neurology 62 2004 925 931
4. K.A. Beck, and J. Nelson The spectrin-based membrane skeleton as a membrane protein-sorting machine Am. J. Physiol. 270 1996 C1263 C1270
5. E. Bonilla, K. Tanji, M. Hirano, T.H. Vu, S. DiMauro, and E.A. Schon Mitochondrial involvement in Alzheimer's disease Biochim. Biophys. Acta 1410 1999 171 182
6. D. Boyd-Kimball, H. Mohmmad Abdul, T. Reed, R. Sultana, and D.A. Butterfield Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity Chem. Res. Toxicol. 17 2004 1743 1749
7. D. Boyd-Kimball, R. Sultana, H.F. Poon, B.C. Lynn, F. Casamenti, G. Pepeu, J.B. Klein, D.A. Butterfield, Proteomic identification of proteins specifically oxidized by intracerebral injection of Aβ(1-42) into rat brain: implications for Alzheimer's disease, Neuroscience (in press).
8. D.A. Butterfield Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain Free Radical Res. 36 2002 1307 1313
9. D.A. Butterfield Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences Curr. Med. Chem. 10 2003 2651 2659
10. D.A. Butterfield Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain Brain Res. 1000 2004 1 7
11. D.A. Butterfield, and A. Castegna Energy metabolism in Alzheimer's disease brain: insights from proteomics Appl. Genomics Proteomics 2 2003 67 70
12. D.A. Butterfield, and A. Castegna Proteomic analysis of oxidatively modified proteins in Alzheimer's disease brain: insights into neurodegeneration Cell. Mol. Biol. 49 2003 747 751
13. D.A. Butterfield, and A. Castegna Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders Amino Acids 25 2003 419 425
14. D.A. Butterfield, and C.M. Lauderback Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress Free Radical Biol. Med. 32 2002 1050 1060
15. D.A. Butterfield, J. Drake, C. Pocernich, and A. Castegna Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide Trends Mol. Med. 7 2001 548 554
16. D.A. Butterfield, A. Castegna, C.M. Lauderback, and J. Drake Evidence that amyloid β-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death Neurobiol. Aging 23 2002 655 664
17. D.A. Butterfield, D. Boyd-Kimball, and A. Castegna Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration J. Neurochem. 86 2003 1313 1327
18. H. Cai, Y. Wang, D. McCarthy, H. Wen, D.R. Borchet, D.L. Price, and P.C. Wong BACE1 is the major β-secretase for generation of Aβ peptides by neurons Nat. Neurosci. 4 2001 233 234
19. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Marksbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain part I: creatine kinase BB, glutamine synthetase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radical Biol. Med. 33 2002 562 571
20. A. Castegna, M. Aksenov, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, α-enolase, and heat shock cognate 71 J. Neurochem. 82 2002 1524 1532
21. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J. Neurochem. 85 2003 1394 1401
22. A. Castegna, V. Thongboonkerd, J. Klein, B.C. Lynn, Y.L. Wang, H. Osaka, K. Wada, and D.A. Butterfield Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl-terminal hydrolase L-1, reveals oxidation of key proteins J. Neurochem. 88 2004 1540 1546
23. D. Champagne, D. Pearson, D. Dea, J. Rochford, and J. Poirier The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease Neuroscience 121 2003 99 110
24. K. Chandrasekaran, K. Hatanpaa, S.I. Rapoport, and D.R. Brady Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neucortex in Alzheimer's disease Brain Res., Mol. Brain Res. 44 1997 99 104
25. P.D. Coleman, and D.G. Flood Neuron numbers and dendritic extent in normal aging and Alzheimer's disease Neurobiol. Aging 8 1987 521 545
26. H. Crystal, D. Dickson, P. Fuld, D. Masur, R. Scott, M. Mehler, J. Masdeu, C. Kawas, M. Aronson, and L. Wolfson Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease Neurology 38 1988 1682 1687
27. S.T. DeKosky, and S.W. Scheff Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity Ann. Neurol. 27 1990 457 464
28. J. Drake, C.D. Link, and D.A. Butterfield Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model Neurobiol Aging 24 2003 415 420
29. C.E. Finch Neurons, glia, and plasticity in normal brain aging Adv. Gerontol. 10 2002 35 39
30. K. Gengyo-Ando, H. Kitayama, M. Mukaida, and Y. Ikawa A murine neural-specific homolog corrects cholinergic deficits in Caenorhabditis elegans unc-18 mutants J. Neurosci. 16 1996 6695 6702
31. N.C. Hall, J.M. Carney, M.S. Cheng, and D.A. Butterfield Ischemia/reperfusion induced changes in membrane proteins and lipids in gerbil cortical synaptosomes Neuroscience 64 1995 81 89
32. J.E. Hamos, L.J. DeGennaro, and D.A. Drachman Synaptic loss in Alzheimer's disease and other dementias Neurology 39 1989 355 361
33. H. He, M. Chen, K. Scheffler, B.W. Gibson, L.L. Spremulli, and R.A. Gottlieb Phosphorylation of mitochondrial elongation factor tu in ischemic myocardium: basis for chloramphenicol-mediated cardioprotection Circ. Res. 89 2001 461 467
34. K. Hensley, N. Hall, R. Subramaniam, P. Cole, M. Harris, M. Aksenov, M. Aksenova, P. Gabbita, J.F. Wu, J.M. Carney, M. Lovell, W.R. Markesbery, and D.A. Butterfield Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation J. Neurochem. 65 1995 2146 2156
35. J. Hu, K.T. Akama, G.A. Krafft, B.A. Chromy, and L.J. Van Eldik Amyloid-beta peptide activates cultures astrocytes: morphological alterations, cytokine induction and nitric oxide release Brain Res. 785 1998 195 206
36. L.L. Iversen, R.J. Mortishire-Smith, S.J. Pollack, and M.S. Shearman The toxicity in vitro of beta-amyloid protein Biochem. J. 311 1995 1 16
37. S.J. Johnson, and C.E. Finch Changes in gene expression during brain aging: a survey E.L. Schneider J.W. Rowe Handbook of the Biology of Aging 3rd ed. 1996 Academic Press San Diego 300 327
38. S.H. Kim, R. Vlkoliský, and G. Lubec Decreased levels of complex III core protein 1 and complex V b chain in brains from patients with Alzheimer's disease and Down syndrome Cell. Mol. Life Sci. 57 2000 1810 1816
39. S.H. Kim, R. Vlkolinský, N. Cairns, M. Fountoulakis, and G. Lubec The reduction of NADH ubiquinone oxidoreducatase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease Life Sci. 68 2001 2741 2750
40. C.M. Lauderback, J.M. Hackett, F.F. Huang, J.N. Keller, L.I. Szweda, W.R. Markesbery, and D.A. Butterfield The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta 1-42 J. Neurochem. 78 2001 413 416
41. C.M. Lauderback, J. Kanski, J.M. Hackett, N. Maeda, M.S. Kindy, and D.A. Butterfield Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner Brain Res. 924 2002 90 97
42. R.L. Levine, J.A. Williams, E.R. Stadtman, and E. Shacter Carbonyl assays for determination of oxidatively modified proteins Methods Enzymol. 233 1994 346 357
43. G. Lubec, M. Nonaka, K. Krapfenbauer, M. Gratzer, N. Cairns, and M. Fountoulakis Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level J. Neural Transm., Suppl. 57 1999 161 177
44. M. Manczak, B.S. Park, Y. Jung, and P.H. Reddy Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage Neuromol. Med. 5 2004 147 162
45. E. Masliah, M. Mallory, L. Hansen, R. De Teresa, M. Alford, and R. Terry Synaptic and neuritic alterations during the progression of Alzheimer's disease Neurosci. Lett. 174 1994 67 72
46. E. Masliah, M. Alford, R. DeTeresa, M. Mallory, and L. Hansen Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease Ann. Neurol. 40 1996 759 766
47. M.P. Mattson, J. Partin, and J.G. Begley Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites Brain Res. 807 1998 167 176
48. C. Messier, and M. Gagnon Glucose regulation and brain aging J. Nutr. Health Aging 4 2000 208 213
49. H. Mohmmad Abdul, G.L. Wenk, M. Gramling, B. Hauss-Wegrzyniak, and D.A. Butterfield APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease Neurosci. Lett. 368 2004 148 150
50. T.E. Morgan, I. Rozovsky, S.K. Goldsmith, D.J. Stone, T. Yoshida, and C.E. Finch Increased transcription of the astrocyte gene GFAP during middle-age is attenuated by food restriction: implications for the role of oxidative stress Free Radical Biol. Metab. 23 1997 524 528
51. R.G. Nagele, M.R. D'Andrea, W.J. Anderson, and H.Y. Wang Intracellular accumulation of β-amyloid (1-42) in neurons is facilitated by the α7 nicotinic receptor in Alzheimer's disease Neuroscience 110 2002 199 211
52. H.F. Poon, V. Calabrese, G. Scapagnini, and D.A. Butterfield Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress J. Gerontol., A, Biol. Sci. Med. Sci. 59 2004 478 493
53. R. Porchet, A. Probst, C. Bouras, E. Draberova, P. Draber, and B.M. Riederer Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease Proteomics 3 2003 1476 1485
54. G.W. Ross, J.P. O'Callaghan, D.S. Sharp, H. Petrovich, D.B. Miller, R.D. Abbott, J. Nelson, L.J. Launer, D.J. Foley, C.M. Burchfiel, J. Hardman, and L.R. White Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease Acta Neurol. Scand. 107 2003 318 323
55. H. Schagger, and T.G. Ohm 1. Human disease with defect in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis Eur. J. Biochem. 227 1995 916 921
56. P. Scheltens, and E.S.C. Korf Contribution of neuroimaging in the diagnosis of Alzheimer's disease and other dementias Curr. Opin. Neurol. 13 2000 391 396
57. S.J. Schonberger, P.F. Edgar, R. Kydd, R.L.M. Faull, and G.J.S. Cooper Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process Proteomics 1 2001 1519 1528
58. D.J. Selkoe Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein J. Alzheimer's Dis. 3 2001 75 80
59. R. Subramaniam, F. Roediger, B. Jordan, M.P. Mattson, J.N. Keller, G. Waeg, and D.A. Butterfield The lipid peroxidation product, 4-hydroxy-2-trans- nonenal, alters the conformation of cortical synaptosomal membrane protein J. Neurochem. 69 1997 1161 1169
60. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
61. V. Thongboonkerd, J. Luengpailin, J. Cao, Q.M. Pierce, J. Cai, J.B. Klein, and R.J. Doyle Fluoride exposure attenuates expression of Streptococcus pyrogenes virulence factors J. Biol. Chem. 277 2002 16599 16605
62. T. Tsuji, S. Shimohama, S. Kamiya, T. Sazuka, and O. Ohara Analysis of brain proteins in Alzheimer's disease using high-resolution two-dimensional gel electrophoresis J. Neurol. Sci. 166 1999 100 106
63. S. Umhauer, D.T. Isbell, and D.A. Butterfield Spin labeling of membrane proteins in mammalian brain synaptic plasma membranes: partial characterization Anal. Lett. 25 1992 1201 1215
64. M. Vanhanen, and H. Soininen Glucose intolerance, cognitive impairment and Alzheimer's disease Curr. Opin. Neurol. 11 1998 673 677
65. M. Verhage, A.S. Maia, J.J. Plomp, A.B. Brussaard, J.H. Heeroma, H. Vermeer, R.F. Toonen, R.E. Hammer, T.K. van den Berg, M. Missler, H.J. Geuze, and T.C. Sudhof Synaptic assembly of the brain in the absence of neurotransmitter secretion Science 287 2000 864 869
66. R.W. Verwer, K.A. Jansen, A.A. Sluiter, C.W. Pool, W. Kamphorst, and D.F. Swaab Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits Exp. Neurol. 163 2000 440 451
67. L.H. Wang, and S.M. Strittmatter A family of rat CRMP genes is differentially expressed in the nervous system J. Neurosci. 16 1996 6197 6297
68. V.P. Whittaker Thirty years of synaptosomes research J. Neurocytol. 22 1993 735 742
69. S.M. Yatin, S. Varadarajan, C.D. Link, and D.A. Butterfield In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42) Neurobiol. Aging 20 1999 325 330